share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Alvarez Ralph

SEC announcement ·  Apr 17 04:16
Summary by Futu AI
Ralph Alvarez, associated with Eli Lilly and Co (LLY), completed a purchase transaction of the company's common stock on April 15, 2024. The transaction involved the acquisition of 16 shares at a price of $750.77 per share. Following this transaction, Alvarez's direct holdings in Eli Lilly and Co amount to 54,029 shares. The total value of the acquired shares at the transaction price is approximately $12,012.32. This transaction reflects a direct investment in the company and indicates Alvarez's continued stake in Eli Lilly's performance.
Ralph Alvarez, associated with Eli Lilly and Co (LLY), completed a purchase transaction of the company's common stock on April 15, 2024. The transaction involved the acquisition of 16 shares at a price of $750.77 per share. Following this transaction, Alvarez's direct holdings in Eli Lilly and Co amount to 54,029 shares. The total value of the acquired shares at the transaction price is approximately $12,012.32. This transaction reflects a direct investment in the company and indicates Alvarez's continued stake in Eli Lilly's performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.